adoseofreality.org
Disproving hypothesis clears path for research for new treatment …
Researchers reported negative results from the first repeated-dose study of a dopamine-1 receptor (D1R) agonist for treating cognitive and negative symptoms of schizophrenia.Based on earlier preclinical research suggesting … Share this:Click to share on Pinterest (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Tumblr (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on Skype (Opens in new window)Click to share on Reddit (Opens in new window)Click to print (Opens in new window)Click to email this to a friend (Opens in new window)Like this:Like Loading...